Omeprazole [Design Issues]

posted by pash413 – India, 2012-12-06 19:09 (4948 d 04:44 ago) – Posting: # 9685
Views: 11,356

Dear all

One small confusion how to control last point Cmax in Fed BE study of prazole DR tablets. In some subjects Cmax is observed in last time points. Shall we exclude data of such subjects from final BE calculation?

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
132 visitors (0 registered, 132 guests [including 26 identified bots]).
Forum time: 00:53 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5